Drug Shortage Report for LOVENOX HP
Report ID | 111405 |
Drug Identification Number | 02242692 |
Brand name | LOVENOX HP |
Common or Proper name | Lovenox HP |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ENOXAPARIN SODIUM |
Strength(s) | 120MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 10 |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-04-13 |
Actual start date | |
Estimated end date | 2020-04-24 |
Actual end date | 2020-04-14 |
Shortage status | Resolved |
Updated date | 2020-04-15 |
Company comments | The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-04-15 | English | Compare |
v5 | 2020-04-14 | French | Compare |
v4 | 2020-04-14 | English | Compare |
v3 | 2020-04-14 | English | Compare |
v2 | 2020-04-07 | French | Compare |
v1 | 2020-04-07 | English | Compare |
Showing 1 to 6 of 6